5th National Forum

Fraud & Abuse in the Sale and Marketing of Drugs

Critical Updates on Enforcement Activity, Civil Liability and Ongoing Compliance Techniques

Monday, October 24, 2005

About


Are You Ready for the New Compliance Challenges Posed by the 2006 Changes to Medicare?

As if the vigilance of federal and state enforcers weren't enough to make you nervous about your sales and marketing compliance efforts, now you have to be ready for a shakeup - on several fronts. The implementation of Medicare Part D, a growing number of state initiatives, and other changes which will create new and challenging compliance obligations in 2006 are sure to have you looking over your shoulder even more.

The risks of non-compliance are significant. Civil and criminal penalties can cost a company hundreds of millions of dollars, and can leave the door open to further risk from civil suits brought by an aggressive plaintiffs' bar. As a result, you must ensure not only that your fraud and abuse compliance strategy is properly implemented and effectively designed, but also that you constantly monitor and maintain it in an effort to avoid being caught up in this ever-widening net of prosecution.

As the need for ongoing and bullet-proof compliance techniques increases, even the most sophisticated corporate counsel, compliance officer, or sales and marketing executive needs an up-to-the-minute understanding of the latest developments affecting the company's obligations. American Conference Institute's Fifth National Forum on Fraud and Abuse in the Sales and Marketing of Drugs publication provides you with the most sophisticated and comprehensive understanding of the most difficult and costly issues facing pharmaceutical companies. An experienced faculty provides you with practical and valuable strategies to tackle today's compliance challenges, as well as insights into how to prepare for tomorrow's enforcement agenda.

Industry experts, including prosecutors from active jurisdictions and experienced outside counsel, highlight what you can learn from the latest criminal and civil actions. In-house counsel and compliance officers from companies such as Alcon Laboratories, Boehringer Ingelheim, Millennium Pharmaceuticals, Novo Nordisk, Organon, Pacific Pulmonary Services, Pfizer, Sanofi-Synthelabo, Schering-Plough, Solvay Pharmaceuticals, and Wyeth provide insights on creating and maintaining effective compliance policies and what steps you can take to minimize your company's exposure.* You are sure to get the information you need to:
  • Comply with the new Medicare Part D and changes to Medicare Part B
  • Analyze and improve the effectiveness of your company's compliance program
  • Monitor and implement compliance with an increasing number of state law initiatives
  • Mitigate potential liability when under investigation by government enforcers
  • Use consultants and other outside experts within permissible boundaries
  • Structure your agreements with wholesalers and distributors to avoid liability


*American Conference Institute cannot guarantee that every presentation will be included in the publication.

Contents & Contributors

About


Are You Ready for the New Compliance Challenges Posed by the 2006 Changes to Medicare?

As if the vigilance of federal and state enforcers weren't enough to make you nervous about your sales and marketing compliance efforts, now you have to be ready for a shakeup - on several fronts. The implementation of Medicare Part D, a growing number of state initiatives, and other changes which will create new and challenging compliance obligations in 2006 are sure to have you looking over your shoulder even more.

The risks of non-compliance are significant. Civil and criminal penalties can cost a company hundreds of millions of dollars, and can leave the door open to further risk from civil suits brought by an aggressive plaintiffs' bar. As a result, you must ensure not only that your fraud and abuse compliance strategy is properly implemented and effectively designed, but also that you constantly monitor and maintain it in an effort to avoid being caught up in this ever-widening net of prosecution.

As the need for ongoing and bullet-proof compliance techniques increases, even the most sophisticated corporate counsel, compliance officer, or sales and marketing executive needs an up-to-the-minute understanding of the latest developments affecting the company's obligations. American Conference Institute's Fifth National Forum on Fraud and Abuse in the Sales and Marketing of Drugs publication provides you with the most sophisticated and comprehensive understanding of the most difficult and costly issues facing pharmaceutical companies. An experienced faculty provides you with practical and valuable strategies to tackle today's compliance challenges, as well as insights into how to prepare for tomorrow's enforcement agenda.

Industry experts, including prosecutors from active jurisdictions and experienced outside counsel, highlight what you can learn from the latest criminal and civil actions. In-house counsel and compliance officers from companies such as Alcon Laboratories, Boehringer Ingelheim, Millennium Pharmaceuticals, Novo Nordisk, Organon, Pacific Pulmonary Services, Pfizer, Sanofi-Synthelabo, Schering-Plough, Solvay Pharmaceuticals, and Wyeth provide insights on creating and maintaining effective compliance policies and what steps you can take to minimize your company's exposure.* You are sure to get the information you need to:
  • Comply with the new Medicare Part D and changes to Medicare Part B
  • Analyze and improve the effectiveness of your company's compliance program
  • Monitor and implement compliance with an increasing number of state law initiatives
  • Mitigate potential liability when under investigation by government enforcers
  • Use consultants and other outside experts within permissible boundaries
  • Structure your agreements with wholesalers and distributors to avoid liability


*American Conference Institute cannot guarantee that every presentation will be included in the publication.

Contents & Contributors


Coming Soon! Email Tina Key, Head Librarian at publications@americanconference.com to be the first to know when this publication becomes available.


DOCUMENT TYPES: PRESENTATIONS AVAILABLE: 0